Hvsen Biotechnology Co., Ltd. (300871.SZ)

11.96 -0.02 (-0.17%) At close: 03:04PM CST

Hvsen Biotechnology Co., Ltd.

No.208 Zhangbai Road
Dongxihu District
Wuhan 430042
China
86 27 8860 5516
https://www.whhsyy.com

Sector(s): Healthcare
Industry: Biotechnology
Full-time employees: 1,068

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Weiyuan Zhang	Chairman & GM	N/A	N/A	1969
Mr. Jie Liu	Vice Chairman & Chief Scientist	N/A	N/A	1964
Mr. Kaijie Yang	Deputy GM & CFO	N/A	N/A	1970
Mr. Zexiang Liu	Director & Assistant to the GM	N/A	N/A	1976
Mr. Jie Han	Deputy General Manager	N/A	N/A	1985
Ms. Hongxia Li	Director of Warehousing & Logistics Data and Supervisor	N/A	N/A	1976
Ms. Jian Zhou	Chairman of the Supervisory Board & Assistant to the GM	N/A	N/A	1974
Mr. Wenge Ding	Product & Technical Service Director and Supervisor	N/A	N/A	1969

Amounts are as of , and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CNY.

Description

Hvsen Biotechnology Co., Ltd. engages in the research and development, and manufacture of macrolides APIs and preparations in China and internationally. Its products include tylvalosin tartrate powders and raw materials; florfenicol, cefquinome sulfate, and tildipirosin injections; and florfenicol powder/WSP, tylosin tartrate soluble powder, and tywasin premix products. The company produces various veterinary drug products of raw materials and preparations, as well as traditional Chinese medicines extractives. Hvsen Biotechnology Co., Ltd. was founded in 2002 and is based in Wuhan, China.

Corporate governance

Hvsen Biotechnology Co., Ltd.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.